×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 4, Track B: Pharmacovigilance Inspections in Latin America – Current Scenario, Expectations and Trends
Session Chair(s)
Arthur Bueno, PharmD, MBA
Country Safety Head Back-Up
Sanofi Brazil, Brazil
In this session, speakers will discuss the current scenario for Pharmacovigilance Inspections in Latin America, considering the main concerns, trends and the expectations from the Regulatory Bodies for the Pharmacovigilance systems for the regulated sector.
Learning Objective : - Recognize the main trends and concerns for Pharmacovigilance Inspections in Latin America
- Understand the Regulatory expectations for the Pharmacovigilance Processes set-up for the regulated sector in Latin America
- Identify opportunities for Pharmacovigilance processes alignments/improvements considering the lessons learned from Pharmacovigilance Inspections in Latin America
Speaker(s)
Session 4, Track B: Pharmacovigilance Inspections in Latin America – Current Scenario, Expectations and Trends
Raphael Elmadjian Pareschi, PharmD, MBA
Roche, Brazil
Patient Safety Lead/ Head of Pharmacovigilance Brazil
Pharmacovigilance Inspections in Latin America: Current Scenario, Expectations and Trends – Scenario for Brazil
Flavia Neves Rocha Alves, MPH
ANVISA, Brazil
PV Department Leader
Pharmacovigilance Inspections in Latin America – Current Scenario, Expectations and Trends
Xiomara Vega Cruz, MHS
Ministry of Health of Costa Rica, Costa Rica
Head of the National Pharmacovigilance Center
Pharmacovigilance Inspections in Peru: Current scenario, Expectations and Trends
Kelly Elizabeth Serrano Mestanza
DIGEMID, Peru
Head of Pharmacovigilance Team
Have an account?